جستجوی استاد راهنمای دانشگاهی

Dr. Joshua Fisher is a Research Fellow at the School of Medicine and Public Health , University of Newcastle, affiliated with the Mother and Babies Research Centre and the Priority Research Centre for Reproductive Science . His research focuses on mitochondrial mechanisms in placental dysfunction and pregnancy complications, including gestational diabetes, preeclampsia, fetal growth restriction, and stillbirth. Y.W (Charlie) Loki Award (2018, 2019) Society of Reproductive Biology Travel Award (2018, 2019) Elsevier New Investigator Award (2021) His publications reveal trends in mitochondrial biology , placental oxidative stress , trace element metabolomics , and gut microbiome interactions in pregnancy. Grants include NHMRC equipment funding and Hunter New England Local Health District awards for projects on mitochondrial therapeutics and genetic origins of FGR. Dr. Fisher supervises PhD students across disciplines, including iron metabolism, prorenin signaling, and endometrial cancer. He advocates for early-career researcher development as an elected ECR representative in ANZPRA and IFPA.

• Mitochondria in Pregnancy
• Placental Biology
• Reproductive Health
• +۳ مورد دیگر

Professor Rona Chandrawati is a faculty member at the University of New South Wales (UNSW) School of Chemical Engineering and Co-Director of the Australian Centre for Nanomedicine. She holds a BSc in Biotechnology from Monash University and a PhD in Chemical and Biomolecular Engineering from the University of Melbourne (2012). Following a Marie Curie Fellowship at Imperial College London, she established her research group in Australia in 2015. Her academic trajectory includes roles as ARC DECRA Fellow, Scientia Senior Lecturer, and promotion to Professor in 2025. Her research integrates nanotechnology, biomaterials, and sensing platforms to address challenges in medicine and food safety. Key areas include: Development of colorimetric nanosensors for pathogens and biomarkers Enzyme-mimetic catalysts for nitric oxide delivery in cardiovascular therapies Nanocoatings for implantable medical devices Polydiacetylene-based systems for food spoilage detection Publication analysis reveals a strong focus on translational applications of nanomaterials, with recurring themes in biosensor innovation, drug delivery optimization, and diagnostic tool development. Her work consistently bridges materials science with clinical and environmental needs. Awards & Honors: Le Fèvre Medal (Australian Academy of Science, 2023) Materials Today Rising Star Award (2022) NSW Early Career Researcher of the Year (2021) World Economic Forum 40 Young Scientists Under 40 (2018) Elsevier Woman in Chemical Engineering Award (2015) She has attracted over AUD 18M in competitive funding as Lead/Co-Chief Investigator, including NHMRC and ARC grants. As head of the NanoFAM Laboratory, she mentors doctoral candidates and postdoctoral researchers, with alumni holding positions at Oxford, Tokyo, and industry leaders. Current teaching includes advanced courses in Particle Systems Engineering and Nanomaterials in Medicine.

• Nanotechnology
• Biosensors
• Drug Delivery
• +۵ مورد دیگر

Professor Elgene Lim is an academic clinician scientist and head of breast cancer services at the Kinghorn Cancer Centre, St Vincent’s Hospital Sydney, and leads the Connie Johnson Breast Cancer Research Laboratory at the Garvan Institute of Medical Research. His work bridges laboratory discoveries and clinical trials, focusing on endocrine therapy resistance and novel therapeutic strategies in breast cancer. Education: MBBS (University of Melbourne, Australia, 1995), PhD (Walter & Eliza Hall Institute, 2010), FRACP (Royal Australasian College of Physicians, 2006). Research Interests: Elgene’s research centers on overcoming endocrine therapy resistance in breast cancer, with a focus on hormone receptors (estrogen, androgen, progesterone) and preclinical models like patient-derived xenografts. His lab integrates high-throughput technologies and translational approaches to develop personalized treatments. Grants: Over $10 million in funding from organizations including Cancer Australia, NHMRC, Cancer Council NSW, National Breast Cancer Foundation, and Garvan Institute. Key grants include the 2017–2027 NBCF Endowed Chair ($5M) and projects targeting CDK4/6 inhibitors, AR signaling, and p53 reactivation. Scientific Awards: National Breast Cancer Foundation Endowed Chair (2017), Connie Johnson Award (2015), Ramaciotti Award (2014), and numerous fellowships and travel awards. Supervision: Currently supervising five PhD students and one oncology fellow, with past mentorship of medical students and physician trainees. His lab employs in vitro, ex vivo, and in vivo models alongside single-cell transcriptomics to study therapeutic interventions. Labs & Collaborations: The Connie Johnson Breast Cancer Research Laboratory at Garvan Institute, where he maintains a large patient tumor repository and xenograft models, collaborates with national and international institutions, and leads clinical trials like the WinPro Study.

• Breast Cancer
• Translational Medical Research
• Clinical Trials
• +۷ مورد دیگر

Professor Murray Killingsworth is a distinguished researcher at the University of New South Wales, Faculty of Medicine, specializing in the Department of Anatomical Pathology at NSW Health Pathology, Liverpool Hospital campus. He is affiliated with the Ingham Institute for Applied Medical Research and leads the Correlative Microscopy Group, a pioneering initiative in Australia focused on applying correlative microscopy principles to ultrastructural studies in cancer cell biology and pathology. His research interests span the cell biology of chronic inflammatory processes in cancer, retinal degeneration, and renal disease. He investigates cell debris clearing by macrophages, stimulation of pathologic angiogenesis, tumor cell motility, and induction of fibrosis. His work employs advanced techniques including correlative light and electron microscopy (CLEM), immunocytochemistry, histochemistry, live cell time-lapse imaging, and image-based morphometry. Analysis of his recent publications reveals a strong focus on the intersection of cell biology, pathology, and imaging. His research spans multiple domains including ophthalmology (particularly age-related macular degeneration), stroke and cerebrovascular disease, pancreatic disorders, and mitochondrial function. The consistent theme across his work is the application of advanced microscopic techniques to understand disease mechanisms at the cellular and subcellular level. Scientific Recognition Lady Mary Fairfax Distinguished Researcher Award (2018) - recognizing his long-standing career with significant research achievements and contributions to the South Western Sydney Local Health District Professor Killingsworth's research supervision focuses on five key areas: Cell biology and immunocytochemistry; Optical, fluorescence, and electron microscopy correlative microscopy (CLEM); Interpretation of morphological and ultrastructural changes related to disease pathogenesis; Morphometry and image analysis; and Presentation of image data for publication and clinical use. His work with the NSW Brain Clot Bank and Age-related Macular Degeneration projects demonstrates his commitment to translating basic science into clinical applications.

• Cell Biology
• Pathology
• Cancer Research
• +۷ مورد دیگر

Conjoint Professor Steven Krilis is affiliated with the University of New South Wales (UNSW) under the Department of Infectious Disease, Immunology and Sexual Health . His research spans immunology, allergy, autoimmune disease, and inflammation , with a focus on protein modifications in conditions like age-related macular degeneration (AMD), sepsis, and antiphospholipid syndrome (APS). Research Interests: Autoimmune thrombosis, mast cell biology, Beta 2-glycoprotein I function, complement factor H, and roles in obesity and angiogenesis. Collaborations: Institutions including Sydney University Millennium Research Centre, Save Sight Institute, Harvard University, John Hopkins University, and University of Melbourne. Professional Memberships & Awards: Elected positions in international societies (IUIS), editorial board memberships, and fellowships in immunology and allergy organizations.

• Immunology
• Allergy
• Asthma
• +۱۴ مورد دیگر

Associate Professor Elissa Deenick is a leading researcher at the Garvan Institute , specializing in immunology and lymphocyte signaling pathways. Her work focuses on understanding the molecular mechanisms that regulate immune responses to infections, using primary human cells and mouse models to study lymphocyte activation, expansion, and differentiation. Research Interests: Immunology, T cells, B cells, Primary Immunodeficiency, Autoimmunity, and lymphocyte signaling Contact: Email e.deenick@garvan.org.au for collaborations or inquiries. Her research supervision extends to ILP, Honours, Masters, and PhD students in immunology-related fields.

• Immunology
• Cellular Immunology
• Autoimmunity
• +۶ مورد دیگر

Professor Kerry-Anne Rye is a Research Professor and Deputy Head of the School of Biomedical Sciences at the University of New South Wales. She heads the Cardiometabolic Disease Research Group and serves as Editor-in-Chief of the Journal of Lipid Research. With a PhD from Flinders University of South Australia (1986) and postdoctoral training at the University of Illinois at Urbana-Champaign, Professor Rye has established herself as a leading researcher in lipoprotein biology and cardiovascular disease. Her research focuses on high density lipoprotein (HDL) structure, function and metabolism, with particular emphasis on the role of HDL in cardiovascular medicine and diabetes. Professor Rye was the first to report that HDLs in human plasma inhibit inflammation in coronary arteries and possess anti-diabetic properties. Her work explores signal transduction pathways in multiple cell types including macrophages, endothelial cells, pancreatic beta cells, and skeletal muscle cells using novel animal models and advanced imaging techniques. Analysis of Professor Rye's recent publications reveals a strong focus on the therapeutic potential of HDL and apolipoproteins, particularly ApoA-I, in treating cardiovascular disease and diabetes. Her research spans from basic molecular mechanisms to clinical applications, with significant work on myeloperoxidase as a therapeutic target, fibroblast growth factor 21 as a biomarker, and novel strategies for reducing cardiovascular events in myocardial infarction survivors. 2012 American Heart Association ATVB Council Special Recognition Award in Arteriosclerosis 2015 American Heart Association ATVB Council Distinguished Achievement Award 2016 UNSW Researcher of the Year Award 2017 American Heart Association ATVB Council Mentor of Women Award 2020 UNSW Faculty of Medicine Award for Academic Research Excellence 2021 Inaugural Fellow of the American Society of Biochemistry and Molecular Biology 2021 NSW Government Ministerial Award for Research Excellence 2023 Jack Oram Award for Outstanding HDL Research Professor Rye currently supervises multiple PhD students (Thomas King, Samson Ogumodede, Iqra Haleem), honors students (William Wang), and postdoctoral fellows (Elias Glaros, Blake Cochran, Jaqueline Ku, Carmen Zhang, Nana Pham). Her research is supported by significant grants including NSW Government Cardiovascular Research Capacity Program funding, National Heart Foundation of Australia Vanguard Grant, NHMRC Ideas Grants, and MRFF Cardiovascular Mission Grant funding. As Deputy Head of the School of Biomedical Sciences and Editor-in-Chief of the Journal of Lipid Research, Professor Rye plays a significant leadership role in both her institution and the broader scientific community. She previously served as Past Chair of the American Heart Association ATVB Council and Immediate Past-Chair of the ATVB Council Nominations Committee.

• Cardiovascular Medicine
• Metabolic Medicine
• Cardiology
• +۵ مورد دیگر

Dr. Michael Fricker is a Research Fellow at the University of Newcastle's School of Medicine and Public Health , specializing in severe asthma and COPD pathogenesis. He leads the ALTEOS clinical cohort study and bridges cell biology with respiratory medicine , having previously identified phagoptosis (cell death via phagocytosis) at University of Cambridge. Academic Appointments : 2016–Present: NHMRC Post-doctoral Research Fellow 2012–2016: Post-doctoral Research Associate 2009–2012: Post-doctoral Researcher, University of Cambridge Research Focus : Cell Death Mechanisms (Apoptosis, Necroptosis, Phagoptosis) Airway Inflammation Subtypes in Asthma/COPD Single-Cell and 'Omic Analyses of Sputum/Blood Biomarker Discovery for Personalized Medicine His recent work employs flow cytometry to identify rare cells like mast cells in sputum, overcoming limitations of conventional microscopy. This technology enables molecular subtyping of asthma and COPD, guiding targeted therapies such as mepolizumab and benralizumab . Scientific Awards : 2018 Vice-Chancellor's Award for Collaboration Excellence 2018 PRC for Healthy Lungs Outstanding Scholar 2015 AstraZeneca Innovation Prize Dr. Fricker has supervised five PhD students, two honours, and one master's student to completion, and currently oversees three PhD candidates. His collaborations span institutions in Australia, UK, and USA , working with leaders like Professor Peter Gibson and Professor Phil Hansbro.

• Pathogenesis of Severe Asthma and COPD
• Advanced single cell and 'omic analyses of airway/blood samples
• Macrophages and Mast Cells in Disease
• +۳ مورد دیگر

Anne-Louise Gannon is a Postdoctoral Research Associate at the University of Newcastle 's School of Environmental and Life Sciences , specializing in endocrinology , nanobiotechnology , and gene editing . She leads the Gannon Group laboratory on Callaghan campus and contributes to the HMRI Ignite Leadership Committee (2018-present). Education: PhD in Adrenal Hormone Regulation , University of Edinburgh (2018) MRes in Cancer Biology , University of Dundee (2014) Biology Honours, University of Dundee (2009) Research Focus: Her work bridges adrenal androgen signaling , nanotechnology for gene therapy , and transgenic mouse models . Key themes include adrenal disease therapeutics , single-injection sterilants , and stress hormone-testis interactions . She employs AAV9-Cre gene targeting , lipid-polymer nanoparticles , and in silico modeling . Publication Impact: Her 2016-2025 output spans ovarian cancer resistance mechanisms , adrenal X-zone biology , and nano-delivery systems , with first-author papers in Endocrinology , FASEB Journal , and Frontiers in Endocrinology . Notable 2024 work includes dual studies on HSD17B enzyme redundancy and microfluidic nanoparticle synthesis . Awards: New Investigator Award , 17th Annual Adrenal Cortex Conference (2016) HMRI Ignite Leadership Committee member Teaching: Lectures on Reproductive Physiology (BIOL3020) at UoN and mentored students through the Women in Reproduction initiative. Supervises PhD projects on epididymal-sperm epigenome links and adrenal nanotherapy .

• Endocrinology
• Nanobiotechnology
• Reproduction
• +۱۰ مورد دیگر

Dr. Anna Hackett is a Conjoint Senior Lecturer in the School of Biomedical Sciences and Pharmacy at the University of Newcastle, specializing in Medical Genetics. With over two decades of research experience, her work primarily focuses on X-linked intellectual disability disorders, genetic diagnostics, and the molecular mechanisms underlying neurodevelopmental conditions. Her research interests encompass a wide range of topics within medical genetics, including X chromosome disorders, noncoding variants in intellectual disability, genomic diagnostics, and the molecular pathways involved in neurodevelopmental disorders. Dr. Hackett has made significant contributions to understanding the genetic basis of X-linked intellectual disability through the identification of novel genes and variants. Analysis of her recent publications reveals a strong focus on advanced genomic technologies for diagnosing intellectual disability, with particular emphasis on X-linked disorders. Her work spans from basic molecular mechanisms to clinical applications, demonstrating a translational research approach that bridges laboratory findings with patient care. She has been instrumental in developing and applying next-generation sequencing techniques for improved diagnostic yield in genetic disorders. Dr. Hackett maintains an active research program with extensive collaborations across multiple institutions in Australia and internationally. Her work has contributed significantly to the understanding of X-linked intellectual disability mechanisms, genomic diagnostics, and the clinical implications of genetic variants. She is frequently involved in large-scale collaborative studies that combine clinical expertise with advanced genomic technologies to improve diagnosis and understanding of genetic disorders.

• Genetics
• Intellectual Disability
• X Chromosome Disorders
• +۴ مورد دیگر

Associate Professor Christian Stricker, affiliated with the John Curtin School of Medical Research at the Australian National University, specializes in multidisciplinary medical research combining electrophysiology, calcium imaging, and computational modeling. His work focuses on synaptic transmission in the cerebral cortex and calcium homeostasis in thymocytes, contributing to understanding learning, memory, and immune system development. Education: MD (University of Zurich), PhD (University of Bern) Research interests center on synaptic plasticity, presynaptic calcium dynamics, and molecular mechanisms of calcium entry in immature T cells. His studies explore how these processes relate to neurodegenerative disorders like Alzheimer's disease and thymic selection mechanisms in collaboration with Professor Chris Parish's Cancer and Vascular Biology group.

• Neuroscience
• Computational Biology
• Calcium Signaling
• +۳ مورد دیگر

Dr Jessica Barnes is a Research Fellow at the University of Newcastle's School of Biomedical Sciences and Pharmacy, affiliated with the Hunter Medical Research Institute (HMRI) and serving as Deputy Theme Leader for the Airway Disease and Vaccines Theme. With a PhD in Immunology and Microbiology (2023), she has made seminal contributions to T cell immunology through her discovery of Th22 cells as a distinct lineage and their T-bet-dependent functional characterisation. University of Newcastle Doctor of Philosophy (Immunology and Microbiology) Bachelor of Biotechnology (Honours) Her research focuses on CD4+ T cell regulation at mucosal surfaces, particularly in respiratory and gastrointestinal infections. Key technical expertise includes flow cytometry , mouse models , transgenic tools , and RNA-sequencing . She leads preclinical studies on host-pathogen interactions and NHMRC-funded projects addressing T cell dysfunction in chronic inflammation like severe asthma. Scientific output includes 13 peer-reviewed publications, over 650 citations, and a Google Scholar h-index of 11. Notable contributions in Mucosal Immunology , Journal of Immunology , and Science Translational Medicine demonstrate her impact in cellular immunology (70%), respiratory diseases (20%), and allergy research (10%). Currently supervising two PhD candidates and contributing to collaborative research efforts, her work spans Translational immunology Vaccine development Host defence mechanisms with particular emphasis on cross-disciplinary applications in inflammation and infection dynamics.

• Cellular immunology
• Respiratory diseases
• T-helper cell differentiation and plasticity
• +۴ مورد دیگر

Tyler Browne serves as a Research Associate at the University of Newcastle's School of Biomedical Sciences and Pharmacy within the College of Health, Medicine and Wellbeing. He works in the Graham Lab, focusing on spinal cord circuitry and pain processing mechanisms. His research bridges neuroanatomy, electrophysiology, and translational pain research with potential clinical applications for chronic pain management. Current Position: Research Associate, School of Biomedical Sciences and Pharmacy Previous Academic Role: Casual Lecturer (2018-2022) Research Focus: Spinal cord dorsal horn circuitry, pain pathways, neural organization Institutional Affiliation: University of Newcastle, Australia Dr. Browne completed his educational training at the University of Newcastle, earning both his Bachelor of Biomedical Sciences (Honours) and Doctor of Philosophy in Human Physiology from the institution. His doctoral research was conducted under Professor Brett Graham in the Spinal Cord Connections Group, establishing the foundation for his ongoing work in neural circuitry related to pain sensation. Dr. Browne's research program centers on understanding how neurons form functional circuits in the dorsal horn of the spinal cord that transmit pain signals to the brain. He investigates spinal projection neurons and their role in conveying nociceptive information, with particular focus on how these circuits become dysregulated in chronic pain states. His work employs advanced techniques including viral vector labeling, patch clamp electrophysiology, transgenic models, and microelectrode array recordings to dissect neural circuitry. The ultimate goal of his research is to identify more selective treatment targets for chronic pain conditions that avoid the limitations of current therapies, which are often ineffective, addictive, or have significant side effects. Analysis of Dr. Browne's publication record reveals a consistent trajectory of increasingly sophisticated investigations into spinal cord circuitry. Starting with foundational work on projection neuron classification, his research has expanded to examine specific interneuron populations, synaptic mechanisms, and circuit-level organization. His publications span high-impact journals in neuroscience and pain research, demonstrating methodological rigor and conceptual advancement in understanding pain pathways. The work shows particular strength in combining anatomical, physiological, and molecular approaches to address complex questions about neural organization in pain processing. Dr. Browne currently serves as co-supervisor for one PhD candidate researching the cellular organization of human spinal cord projection neurons. While specific grant funding isn't detailed in the available information, his sustained publication record across multiple high-impact journals suggests successful research funding support. His collaborative work with multiple co-authors across different institutions indicates an active research network focused on advancing understanding of pain mechanisms. Working within the Graham Lab at the University of Newcastle, Dr. Browne contributes to a research environment dedicated to understanding spinal cord connections and pain pathways. His work intersects with broader efforts to translate basic neuroscience findings into clinical applications for pain management. The lab appears to maintain strong collaborative relationships with other neuroscience researchers, as evidenced by the multi-author publications spanning various specialized techniques in neural circuit analysis.

• Neuroscience
• Neuroanatomy
• Pain Research
• +۳ مورد دیگر

Dr Jonathan Harry Erlich is a researcher at UNSW Sydney, affiliated with the Prince of Wales Clinical School and the Department of Nephrology . His work focuses on cell signaling via the coagulation pathway in inflammation, particularly in cardiac and renal ischemia reperfusion injury (IRI), glomerulonephritis, and chronic renal scarring. Primary Affiliations: Prince of Wales Clinical School, Department of Nephrology, UNSW Sydney Research Themes: Coagulation cascade, Protease Activated Receptors (PAR-1), Therapeutic Target Identification in Renal Injury His current projects employ mouse models to investigate PAR-1 signaling pathways in renal IRI, with recent efforts extending findings to rat models of kidney transplantation. This work aims to develop interventions that mitigate renal damage in clinical contexts such as aortic surgery and transplantation.

• Nephrology
• Urology
• Cardiovascular Medicine
• +۹ مورد دیگر

Dr. Padmaja Tummala is a Postdoctoral Fellow at the Australian National University 's John Curtin School of Medical Research , specializing in protein chemistry and immunology since 2010. Her work bridges enzymology and therapeutic development, focusing on Glutathione S-Transferases (GSTs) in inflammatory diseases and cancer. Education: PhD in Biochemistry (2009), Osmania University Research Highlights: Padmaja combines protein chemistry with translational medicine to study GST-Omega1 (GSTO1) in: Inflammatory disease modulation (colitis, sepsis, fatty liver) NLRP3 inflammasome regulation via NEK7 deglutathionylation Development of GSTO1-targeting drug candidates Autoimmune disorder mechanisms linked to TNIP1 mutations Recent Publications demonstrate her expertise in redox biology and inflammation, with a shift toward autoimmune disease models (2024) and continued GSTO1 research in cancer (2021-2019). Her work includes collaborations across pharmacology, molecular biology, and computational chemistry.

• Protein Chemistry
• Immunology
• Drug Discovery
• +۳ مورد دیگر